New York University School of Medicine-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2017

  1. Reversible dual inhibitor against G9a and DNMT1 improves human iPSC derivation enhancing MET and facilitating transcription factor engagement to the genome

    PLoS ONE, Vol. 12, Núm. 12